Journey Medical (DERM) Change in Cash (2020 - 2026)

Journey Medical has reported Change in Cash for 7 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 309.02% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 305.86% YoY), and the FY2025 full-year result was $3.8 million, up 153.06% from the prior year.
• Change in Cash for Q1 2026 stood at $3.1 million, up from -$858000.0 in the prior quarter.
• The five-year high for Change in Cash was $7.8 million in Q3 2023, with the low at -$9.1 million in Q2 2023.
• Historically, Change in Cash has averaged -$1.3 million across 5 years, with a median of -$1.5 million in 2024.
• The largest YoY upside for Change in Cash was 420.81% in 2025 against a maximum downside of 435.86% in 2025.
• Journey Medical's Change in Cash stood at -$2.9 million in 2022, then jumped by 193.14% to $2.7 million in 2023, then plunged by 180.15% to -$2.2 million in 2024, then soared by 60.2% to -$858000.0 in 2025, then jumped by 464.69% to $3.1 million in 2026.
• The last three Change in Cash figures came in at $3.1 million (Q1 2026), -$858000.0 (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.